These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role. Kull K; Salupere R; Uibo R; Ots M; Salupere V Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879 [TBL] [Abstract][Full Text] [Related]
27. Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value. Glas J; Török HP; Vilsmaier F; Herbinger KH; Hoelscher M; Folwaczny C Digestion; 2002; 66(3):173-7. PubMed ID: 12481163 [TBL] [Abstract][Full Text] [Related]
28. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483 [TBL] [Abstract][Full Text] [Related]
29. Influence of total colectomy on serum antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Patel RT; Stokes R; Birch D; Ibbotson J; Keighley MR Br J Surg; 1994 May; 81(5):724-6. PubMed ID: 8044563 [TBL] [Abstract][Full Text] [Related]
30. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases. Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978 [TBL] [Abstract][Full Text] [Related]